OTC
CO

Opera Trading Capital’s Global Cord Blood Corporation CO Stock Holding History

Opera Trading Capital’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,790
Closed -$45K – 176
2017
Q2 		$45K Hold
4,790
– – 0.01% 128
2017
Q1 		$31K Hold
4,790
– – 0.01% 83
2016
Q4 		$29K Hold
4,790
– – 0.01% 106
2016
Q3 		$24K Hold
4,790
– – 0.01% 107
2016
Q2 		$28K Hold
4,790
– – 0.01% 112
2016
Q1 		$29K Hold
4,790
– – 0.01% 120
2015
Q4 		$30K Buy
+4,790
New +$30.2K 0.01% 97

Other funds holding CO

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PM
Parametrica Management Wanchai, Hong Kong $88M AUM 48.84% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

Opera Trading Capital's CO Position: Q3 2017 in Review

Opera Trading Capital sold out of Global Cord Blood Corporation (CO) in Q3 2017, closing a stake of 4,790 shares — an estimated $45K sold.

Opera Trading Capital first reported a position in CO in Q4 2015 and held it in 7 quarters. The position peaked at $45K in Q2 2017. 52 funds tracked by Wall St. Rank hold CO as of Q3 2017.

  • Opera Trading Capital reported no remaining Global Cord Blood Corporation position as of Q3 2017 after selling out during the quarter.
  • Opera Trading Capital sold 4,790 Global Cord Blood Corporation shares in Q3 2017, an estimated $45K.
  • Opera Trading Capital first reported a position in Global Cord Blood Corporation in Q4 2015 and held it in 7 quarters.
  • Opera Trading Capital's Global Cord Blood Corporation position peaked at $45K in Q2 2017.
  • 52 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2017.

Based on Opera Trading Capital's 13F filing for Q3 2017, filed 6 Nov 2017.